Evidence-based deprescribing of proton pump inhibitors in long-term care.

[1]  C. Kirkpatrick,et al.  Prioritizing interventions to manage polypharmacy in Australian aged care facilities , 2017, Research in social & administrative pharmacy : RSAP.

[2]  S. Guha,et al.  Prevalence and predictors of non‐evidence based proton pump inhibitor use among elderly nursing home residents in the US , 2017, Research in social & administrative pharmacy : RSAP.

[3]  A. Mangoni,et al.  Effectiveness of Interventions to Deprescribe Inappropriate Proton Pump Inhibitors in Older Adults , 2017, Drugs & Aging.

[4]  J. Sluggett,et al.  Medication management policy, practice and research in Australian residential aged care: Current and future directions. , 2017, Pharmacological research.

[5]  E. Roughead,et al.  Use of proton pump inhibitors among older Australians: national quality improvement programmes have led to sustained practice change , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[6]  J. Fastbom,et al.  Long‐term use of proton pump inhibitors and prevalence of disease‐ and drug‐related reasons for gastroprotection—a cross‐sectional population‐based study , 2016, Pharmacoepidemiology and drug safety.

[7]  T. Emery,et al.  Polypharmacy and Medication Regimen Complexity as Risk Factors for Hospitalization Among Residents of Long-Term Care Facilities: A Prospective Cohort Study. , 2016, Journal of the American Medical Directors Association.

[8]  C. Kirkpatrick,et al.  Why is polypharmacy increasing in aged care facilities? The views of Australian health care professionals. , 2016, Journal of evaluation in clinical practice.

[9]  T. Emery,et al.  Are residents of aged care facilities willing to have their medications deprescribed? , 2016, Research in social & administrative pharmacy : RSAP.

[10]  Karl Broich,et al.  Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data Analysis. , 2016, JAMA neurology.

[11]  Eric E. Smith,et al.  The Prevalence and Incidence of Dementia: a Systematic Review and Meta-analysis , 2016, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[12]  J. Mwesige.  Encouraging the Appropriate Use of Proton Pump Inhibitors (PPIs) in Long-Term Care Through a Quality Improvement (QI) Project , 2016 .

[13]  J. Bell,et al.  What factors are important for deprescribing in Australian long-term care facilities? Perspectives of residents and health professionals , 2016, BMJ Open.

[14]  S. Koch,et al.  Use of Quality Indicators in Nursing Homes in Victoria, Australia , 2014, Journal of aging and health.

[15]  M. Gorbien,et al.  Use of proton pump inhibitors with lack of diagnostic indications in 22 Midwestern US skilled nursing facilities. , 2013, Journal of the American Medical Directors Association.

[16]  M. Lapeyre-Mestre,et al.  Prevalence and associations of the use of proton-pump inhibitors in nursing homes: a cross-sectional study. , 2013, Journal of the American Medical Directors Association.

[17]  Jimmy D Bell,et al.  Risk of death associated with use of PPIs in three cohorts of institutionalized older people in Finland. , 2012, Journal of the American Medical Directors Association.

[18]  E. Roughead,et al.  Initiation and duration of proton pump inhibitors in the Australian veteran population , 2012, Internal medicine journal.

[19]  I. Zuckerman,et al.  Medication reconciliation during the transition to and from long-term care settings: a systematic review. , 2012, Research in social & administrative pharmacy : RSAP.

[20]  E. Lawler,et al.  Proton Pump Inhibitor Discontinuation in Long‐Term Care , 2011, Journal of the American Geriatrics Society.

[21]  C. Glew,et al.  Use of proton pump inhibitors and other acid suppressive medications in newly admitted nursing facility patients. , 2007, Journal of the American Medical Directors Association.